In the News

Share
1721 News Items found
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs
By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center Named in Fast Company’s First Annual List of “Brands That Matter”
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
New Finding Could Predict Which People with Lung Cancer Will Benefit from Chemotherapy
Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
Announcement
Promising PhD Students Awarded Funding to Support Doctoral Research at Gerstner Sloan Kettering
“We could not be more proud of this deserving group of the outstanding GSK students who have been recognized with fellowship support this academic year,” says GSK Dean Michael Overholtzer.
Reina Honts with her husband, John, and their two children, Julian and Reine
Cancer Straight Talk: Addressing the Stigma of Lung Cancer
Diane Reidy-Lagunes sits down with pioneering thoracic surgeon Bernard Park and lung cancer survivor Reina Honts to discuss the stigma surrounding lung cancer.
Shari Goldfarb, MD
Memorial Sloan Kettering Highlights Important Research to Commemorate Breast Cancer Awareness Month
In recognition of Breast Cancer Awareness Month, MSK shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers.
Charles Rudin and Dana Pe'er
Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive
Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.
Cesar Figueroa Ortiz posing for a photo with his parents
Home at Last: Cesar Figueroa Ortiz
Meet Cesar Figueroa Ortiz, who says, “The mission of MSK really resonated with me, all the employees seemed very happy, and the patients said great things about their care.”
Ask the Expert
Memorial Sloan Kettering surgeon Andrea Barrio
What Is Ductal Carcinoma In Situ (DCIS), and How Do I Decide on the Right Treatment?
Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.